RadNet, Inc. (RDNT)
| Market Cap | 4.50B |
| Revenue (ttm) | 2.04B |
| Net Income (ttm) | -18.65M |
| Shares Out | 78.27M |
| EPS (ttm) | -0.25 |
| PE Ratio | n/a |
| Forward PE | 91.31 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 507,481 |
| Open | 57.85 |
| Previous Close | 57.75 |
| Day's Range | 55.79 - 58.42 |
| 52-Week Range | 49.83 - 85.84 |
| Beta | 1.53 |
| Analysts | Strong Buy |
| Price Target | 82.80 (+43.9%) |
| Earnings Date | May 11, 2026 |
About RDNT
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 5 analysts, the average rating for RDNT stock is "Strong Buy." The 12-month stock price target is $82.8, which is an increase of 43.90% from the latest price.
News
GE HealthCare expands mammography collaboration with RadNet's DeepHealth subsidiary to extend global access to DeepHealth's AI-powered breast cancer screening solutions
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced an expanded collaboration with DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary o...
RadNet Transcript: 2026 KeyBanc Capital Markets Healthcare Forum
Strong growth in advanced imaging and digital health, driven by acquisitions, technology upgrades, and AI innovation, is expected to continue in 2026. Hospital joint ventures and regulatory trends support expansion, while the Gleamer acquisition positions the company as a global AI leader.
RadNet Transcript: Barclays 28th Annual Global Healthcare Conference
Record revenue and margin growth were highlighted, with strong MRI and PET CT volumes and a positive 2026 outlook. Digital health is set for over 50% growth, driven by acquisitions like Gleamer, which expands AI capabilities and synergies. Labor efficiencies and advanced imaging trends support sustained margin improvement.
RadNet Transcript: M&A announcement
The acquisition of Gleamer adds advanced X-ray AI capabilities, accelerating global expansion and automated reporting initiatives. Significant cost and revenue synergies are expected, with rapid integration and deployment planned for 2024. Break-even is targeted by mid-2027.
RadNet, Inc. Reminds Investors of the Dedicated Conference Call and Presentation About the Recently Completed Acquisition of Gleamer SAS
LOS ANGELES, March 04, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and oper...
RadNet Transcript: 47th Annual Raymond James Institutional Investor Conference
Imaging and digital health revenues are set for strong growth in 2026, driven by advanced imaging, acquisitions, and AI integration. Margin expansion is expected as technology and automation offset rising labor costs. Multiple FDA approvals and international expansion further support the outlook.
RadNet, Inc. to Present at the Raymond James 47th Annual Institutional Investors Conference on Tuesday, March 3rd, 2026
LOS ANGELES, March 02, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned an...
RadNet Transcript: Investor update
RadNet's acquisition of Gleamer, integrated into DeepHealth, creates the largest radiology AI provider globally, with a combined portfolio covering over 75 indications and strong financial growth projections. The integration accelerates automation in diagnostics, enhances operational efficiency, and positions the entity as a leader in clinical AI.
RadNet Earnings Call Transcript: Q4 2025
Record Q4 and full-year 2025 results featured double-digit revenue and EBITDA growth, strong Digital Health expansion, and the transformative acquisition of Gleamer, positioning DeepHealth as the global leader in radiology AI. 2026 guidance calls for robust revenue, margin, and ARR growth.
RadNet Reports Fourth Quarter 2025 Results, Including Record Revenue and Adjusted EBITDA⁽¹⁾ and Releases 2026 Financial Guidance
LOS ANGELES, March 02, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a ne...
DeepHealth Achieves CE Mark for TechLive™ and Enables AWS Marketplace Deployment, Advancing Global Expansion of Multimodality Vendor-Agnostic Remote Scanning Solution
DeepHealth's TechLive remote scanning solution achieves CE marking for Europe, accelerated commercial traction in the U.S. and AWS Marketplace availability
RadNet, Inc. Announces Date of its Fourth Quarter 2025 Financial Results Conference Call
LOS ANGELES, Feb. 17, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and opera...
RadNet Enters Indiana with Acquisition of Northwest Radiology
LOS ANGELES, Feb. 03, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services and a global developer of...
RadNet Transcript: 44th Annual J.P. Morgan Healthcare Conference
Healthcare is rapidly shifting toward ambulatory care and AI-driven early detection, with radiology at the forefront of digital transformation. The business is expanding through acquisitions, joint ventures, and innovative digital health solutions, projecting double-digit growth in both core and digital segments.
RadNet, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference January 14th, 2026
LOS ANGELES, Jan. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and...
RadNet Expands to Southwest Florida with Acquisition of Radiology Regional
LOS ANGELES, Jan. 07, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services and a global developer of...
RadNet Stock Hit By Short Seller Report, Questions AI Hype, Growth Claims
RadNet, Inc. (NASDAQ: RDNT) stock is trading lower on Tuesday. Hunterbrook Capital released a short report on Tuesday on the company, stating that the smaller companies are slapping "AI" on their pitc...
DeepHealth Launches Breast Suite, Elevating Breast Cancer Detection, Risk Stratification and Workflow
Breast Suite is an industry-leading, comprehensive, and modular AI-powered suite of applications supporting more than 10 million mammograms annually delivering increased breast cancer detection rates,...
DeepHealth Unveils Next-Generation Imaging Informatics and Clinical AI Solutions at RSNA 2025, Advancing a New Standard of AI-Powered Care
CHICAGO, Nov. 30, 2025 (GLOBE NEWSWIRE) -- DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), today unveils an expanded portfoli...
Landmark Nature Health Study Demonstrates the Effectiveness of DeepHealth's Novel AI-Powered Breast Cancer Detection Workflow
Largest real-world analysis of AI-driven breast cancer screening in US demonstrates increased cancer detection rate, consistency across patient populations
GE HealthCare and RadNet's DeepHealth Division Sign Letter of Intent to Advance Innovation and Adoption of AI-Powered Imaging Across Multiple Modalities and Remote Scanning
GE HealthCare and RadNet's DeepHealth Division Sign Letter of Intent to Advance Innovation and Adoption of AI-Powered Imaging Across Multiple Modalities
RadNet Transcript: Investor Day 2025
RadNet outlined a strategy focused on AI-driven, cloud-native innovation, expanding outpatient imaging, and proactive prevention. Financial guidance calls for double-digit revenue growth, margin expansion, and rapid scaling of digital health and advanced imaging, supported by strong cash reserves and disciplined capital deployment.
RadNet Acquires CIMAR UK, Empowering DeepHealth to Accelerate AI-Powered Imaging, Reporting and Image-Based Screening
Acquisition supplements CIMAR's cloud-native infrastructure with DeepHealth's AI-powered informatics to deliver connected, efficient and accessible care
RadNet Earnings Call Transcript: Q3 2025
Record Q3 revenue and adjusted EBITDA were driven by strong Advanced Imaging growth, robust Digital Health performance, and successful integration of iCAD and See-Mode. Guidance for 2025 was raised, and 2026 Medicare reimbursement is expected to provide a revenue uplift.
RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA¹ and Revises Upwards 2025 Financial Guidance Ranges
LOS ANGELES, Nov. 09, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services and a premier global deve...